Pharmacokinetic parameters of lopinavir determined by moment analysis in Japanese HIV type 1-infected patients.
Takahashi
Masaaki
M
Kudaka
Yuichi
Y
Okumura
Naoya
N
Hirano
Atsushi
A
Banno
Kazuhide
K
Kaneda
Tsuguhiro
T
D000328:Adult; D019380:Anti-HIV Agents / Q000008:administration & dosage; D019540:Area Under Curve; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000493:pharmacokinetics*; D015497:HIV-1 / Q000187:drug effects; D006207:Half-Life; D006801:Humans; D007564:Japan; D061466:Lopinavir; D008297:Male; D008875:Middle Aged; D011744:Pyrimidinones / Q000008:administration & dosage / Q000493:pharmacokinetics*; D018894:Reverse Transcriptase Inhibitors / Q000008:administration & dosage
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D011744:Pyrimidinones; D018894:Reverse Transcriptase Inhibitors; D061466:Lopinavir